AdvisorShares Psychedelics ETFPSIL
- AUM
- $42M
- Fee
- 1.28%
- Yield
- 8.7%
- Bumpy · 1Y
- 2.9×S&P
- Volume
- 17K
- NAV
- $19.42
52-week range28% below the high
$15.63$27.02
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | +4.0% | −7.6% | −21.5% | +12.9% | +18.7% | +55.4% | −76.0% | −77.4% |
| S&P 500 · VOO | +0.3% | −5.0% | −4.6% | +8.7% | +9.8% | +80.8% | +71.8% | — |
PSIL in One Breath
PSIL Among Its Peers
YTDEnd-of-day Nov 8, 2026 · 1 ETFs by YTD
$10,000 in PSIL
5Y$10,000 in PSIL became
$2,399
In the S&P 500 (VOO)
$17,177
Total return, dividends in · Oct 29, 2021 – Nov 6, 2026 · S&P 500 uses VOO
PSIL’s Top Holdings
TodayDFTXDefinium Therapeutics11.5%CMPS9.4%HELP7.9%LLY6.6%ABBV6.1%RLMD6.0%NBIX5.9%STIM5.7%SPTX5.3%JNJ4.9%INDV4.7%GHRS4.4%ANRO4.1%NRXP3.8%DRUG2.4%QNTM2.1%NEUP2.0%PBM1.9%OPTH1.6%IXHLIGC3 more
DFTXDefinium Therapeutics11.5%CMPS9.4%HELP7.9%LLY6.6%ABBV6.1%RLMD6.0%NBIX5.9%STIM5.7%SPTX5.3%JNJ4.9%INDV4.7%GHRS13 more
BiotechnologyDrug Manufacturers - GeneralMedical - PharmaceuticalsMedical - DevicesDrug Manufacturers - SpecialtyOther
AdvisorShares PSIL · 25 holdings · tile size = share of the fund · as of Nov 6, 2026
What PSIL Holds
TodayBiotechnology52.8%
DFTX 11.5 · CMPS 9.4 · RLMD 6.0 · NBIX 5.9 · SPTX 5.3 · GHRS 4.4 · ANRO 4.1
Drug Manufacturers - General17.6%
LLY 6.6 · ABBV 6.1 · JNJ 4.9
Medical - Pharmaceuticals7.9%
HELP 7.9
Medical - Devices5.7%
STIM 5.7
Drug Manufacturers - Specialty & Generic4.7%
INDV 4.7
Other holdings11.2%
QNTM 2.1 · NEUP 2.0 · PBM 1.9 · OPTH 1.6 · IXHL · IGC · NUMIF
AdvisorShares PSIL · share of the fund by industry · as of Nov 6, 2026
Definium’s Share of PSIL
Today11.5%
$115 of every $1,000 in PSIL is Definium
Definium held by PSIL
$4.8M
AdvisorShares PSIL · each square = $10 of $1,000 · as of Nov 6, 2026
PSIL’s Size vs Its Peers
Today$41.8Mthe largest ETF
AUM · PSIL and the 0 largest peers · Nov 8, 2026
PSIL Fee per $100 vs Peers
TodayExpense ratio · peers · Nov 8, 2026
Inside PSIL
25 holdings · as of Nov 6, 2026PSIL
AdvisorShares Psychedelics ETF
TodayBiotechnology52.8%DFTXDefinium Therapeutics11.5%CMPS9.4%RLMD6.0%NBIX5.9%SPTX5.3%GHRS4.4%ANRO4.1%NRXP3.8%DRUGDrug Manufacturers - General17.6%LLY6.6%ABBV6.1%JNJ4.9%Medical - Pharmaceuticals7.9%HELP7.9%Medical - Devices5.7%STIM5.7%Drug Manufacturers - Specialty4.7%INDVOther11.2%QNTMNEUPPBMOPTHIXHLIGCNUMIFSILO
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | DFTX | Definium Therapeutics | 11.53% |
| 2 | CMPS | Compass Pathways | 9.38% |
| 3 | HELP | Helus Pharma | 7.91% |
| 4 | LLY | ELI Lilly & | 6.63% |
| 5 | ABBV | Abbvie | 6.06% |
| 6 | RLMD | Relmada Therapeutics | 6.01% |
| 7 | NBIX | Neurocrine Biosciences | 5.93% |
| 8 | STIM | Neuronetics | 5.72% |
| 9 | SPTX | Seaport Therapeutics | 5.28% |
| 10 | JNJ | Johnson & Johnson | 4.89% |
BiotechnologyDrug Manufacturers - GeneralMedical - PharmaceuticalsMedical - DevicesDrug Manufacturers - SpecialtyOther
AdvisorShares PSIL · current holdings by weight · as of Nov 6, 2026 · each tile is one holding · top 20 = 97.1%
All PSIL Holdings
29 holdings · as of Nov 6, 2026PSIL
PSIL’s Holdings
Today| # | ||||||
|---|---|---|---|---|---|---|
| 1 | DFTXDefinium Therapeutics | Healthcare | 11.53% | $1,152.96 | 153K | $4.6M |
| 2 | CMPSCompass Pathways | Healthcare | 9.38% | $938.26 | 484K | $3.8M |
| 3 | HELPHelus Pharma | Healthcare | 7.91% | $791.01 | 380K | $3.2M |
| 4 | LLYELI Lilly | Healthcare | 6.63% | $663.40 | 1,960 | $2.7M |
| 5 | ABBVAbbvie | Healthcare | 6.06% | $605.56 | 8,471 | $2.4M |
| 6 | RLMDRelmada Therapeutics | Healthcare | 6.01% | $601.37 | 643K | $2.4M |
| 7 | NBIXNeurocrine Biosciences | Healthcare | 5.93% | $592.51 | 15K | $2.4M |
| 8 | STIMNeuronetics | Healthcare | 5.72% | $571.72 | 949K | $2.3M |
| 9 | SPTXSeaport Therapeutics | Healthcare | 5.28% | $527.61 | 104K | $2.1M |
| 10 | JNJJohnson & Johnson | Healthcare | 4.89% | $489.11 | 7,242 | $2.0M |
| 11 | INDVSupernus | Healthcare | 4.73% | $473.12 | 71K | $1.9M |
| 12 | GHRSGH Research | Healthcare | 4.44% | $443.79 | 97K | $1.8M |
| 13 | ANROAlto Neuroscience | Healthcare | 4.11% | $411.39 | 76K | $1.7M |
| 14 | NRXPNRX Pharmaceuticals | Healthcare | 3.78% | $377.66 | 671K | $1.5M |
| 15 | DRUGBright Minds Biosciences | Healthcare | 2.37% | $237.27 | 46K | $957K |
AdvisorShares PSIL · every reported holding · per $10,000 = dollars of each holding in a $10,000 stake · as of Nov 6, 2026
How It Compares
PSIL
AdvisorShares Psychedelics ETF’s Peers
TodayPSIL has no close peers in our data yet: […]
Similar peers · Today’s and past-year returns · as of Nov 9, 2026 · sorted by AUM
Head to Head
PSIL vs VOO
YTDPSIL · AdvisorShares Psychedelics
+12.9%
VOO · S&P 500
+8.7%
Gap
4.2 pts
AdvisorShares PSIL and Vanguard VOO · Today total return · as of Nov 9, 2026
PSIL vs Its Peer Average
YTDPSILAvsBPeer average
1D+4.0%[…]
1M−7.6%[…]
3M−21.5%[…]
YTD+12.9%[…]
1Y+18.7%[…]
3Y+55.4%[…]
5Y−76.0%[…]
0–0level
0 peers · each row scaled to its leader
How Bumpy Is PSIL?
ViewPSIL
How Bumpy
1Y2.9×the S&P 500’s swings
CalmerBumpierS&P 1×PSIL
S&P 500 swings · 1Y13.6%
AdvisorShares PSIL · daily swings over the past year vs the S&P 500
PSIL
Worst Drop
1Y−30.4%from its Aug 25 high
Still below the high−27.6%
$10,000 at the high is now$7,240
AdvisorShares PSIL · fall from the highest close, past year
PSIL
On a Bad Day
1Y1.2×the S&P 500’s fall
PSIL’s worst day: Monday, Nov 2Up days50 of every 100
S&P 500 up days52 of every 100
AdvisorShares PSIL · average move on days the S&P 500 fell
PSIL
Return for the Bumps
1YNo peers with a full year of prices to rank against yet.
Ranked by return above cash for each unit of bumpiness (Sharpe ratio) · cash = 3.8%
PSIL
Cost
Today$128a year per $10,000
Expense ratio 1.28%, taken from the fund’s value
PSIL
Volatility & Beta
1Y39.9%annual volatility
S&P 500 volatility13.6%
Downside volatility26.6%
Beta vs SPY1.18
Correlation vs SPY0.40
Daily total returns × √252 · past 254 trading days
PSIL
Max Drawdown
1Y−30.4%peak to trough
Peak closeAug 25, 2026
Current drawdown−27.6%
Worst day−9.14% · Nov 2
Closing prices, dividends in
PSIL
Up / Down Capture
1Y119%down capture vs SPY
Up ÷ down capture1.08
Up days50.0% (S&P 52.0%)
Average daily move on SPY up days and down days
PSIL
Sharpe & Sortino vs Peers
1Y| Fund | Sharpe | Sortino | Volatility | Max DD | Beta | Fee / $10k |
|---|---|---|---|---|---|---|
| PSIL | 0.22 | 0.33 | 39.9% | −30.4% | 1.18 | $128 |
Sharpe = (return − 3.8% cash) ÷ volatility · Sortino uses downside volatility only
PSIL
Trading
Today−0.15%below its holdings’ value
Close$19.39
NAV$19.42
Fee per $10,000$128 a year
Avg. volume 30D23K shares
Close vs net asset value, Nov 6
The Details
PSIL
Fund Facts
Today2021launched Sep 15
Tracks[…]
Exchange · CUSIPAMEX · 00768Y297
StructureETF
Leverage1x
Cost on $10,000$128 a year
Go deeper
AdvisorShares PSIL · fund facts · as of Nov 9, 2026
PSIL
Payouts by Year
4Y$1.68per share, Dec 2025
Distribution yield8.7%
PaidEvery quarter
Latest ex-date · paidDec 22 · Dec 29, 2025
8 payouts added up$2.62 a share
AdvisorShares PSIL · distributions by ex-date · 2022–2025
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-06-30 ↗SEC reported portfolio · 2026-03-31 ↗SEC reported portfolio · 2025-12-31 ↗SEC reported portfolio · 2025-09-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-06-30 ↗SEC reported portfolio · 2025-03-31 ↗SEC reported portfolio · 2024-12-31 ↗SEC reported portfolio · 2024-09-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-06-28 ↗SEC reported portfolio · 2024-03-28 ↗SEC reported portfolio · 2023-12-29 ↗SEC reported portfolio · 2023-09-29 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-06-30 ↗SEC reported portfolio · 2023-03-31 ↗SEC reported portfolio · 2022-12-30 ↗SEC reported portfolio · 2022-09-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-06-30 ↗SEC reported portfolio · 2022-03-31 ↗SEC reported portfolio · 2021-12-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2021-09-30 ↗prospectus · SEC 485BPOS ↗
Trading & Liquidity
Net asset value$19.42
Premium / discount[…]
Median spread · 30D[…]
Volume today17K
Average volume · 30D23K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio1.28%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$128.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 29, 2025 | $1.68 |
| Sep 22, 2025 | Sep 29, 2025 | $0.0201 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0119 |
| Mar 21, 2025 | Mar 28, 2025 | $0.16 |
| Dec 23, 2024 | Dec 30, 2024 | $0.0548 |
| Sep 23, 2024 | Sep 30, 2024 | $0.11 |
| Sep 25, 2023 | Sep 29, 2023 | $0.0336 |
| Sep 26, 2022 | Sep 30, 2022 | $0.54 |
Issuer contentFrom AdvisorSharesHear the strategy from the people behind PSIL.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →